Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: Results of a prospective multicenter study

Obesity Surgery

Volumn 17, Issue 6, 2007, Pages 764-769

  Mion, François ^a,b   Gincul, Rodica ^e   Roman, Sabine ^a,b   Beorchia, Sylvain ^c   Hedelius, Frank ^d   Claudel, Nicolas ^e   Bory, Roger Michel ^f   Malvoisin, Etienne ^a   Trepo, Frédérique ^a   Napoleon, Bertrand ^f  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Clinique de la Sauvegarde   (France)

^d CLINIQUE PASTEUR   (France)

^e Polyclinique du Beaujolais ^*

^f Clinique Sainte Anne Lumière   (France)

Author keywords

Ghrelin; Human; Intra gastric balloon; Obesity

Indexed keywords

GHRELIN;

ABDOMINAL PAIN; ADULT; AIR; ARTICLE; BALLOON; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; DIET RESTRICTION; FEMALE; GASTRIC BANDING; GENERAL ANESTHESIA; HORMONE BLOOD LEVEL; HUMAN; MALE; MORBID OBESITY; MULTICENTER STUDY; NAUSEA; OBESITY; PATIENT MONITORING; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; STATISTICAL SIGNIFICANCE; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AIR; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; GASTRIC BALLOON; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 34347224053     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-007-9141-z     Document Type: Article

References (27)

1. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO; 1998.
2. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005; 61: 19-27.
3. Genco A, Bruni T, Doldi SB et al. BioEnterics intragastric balloon: The Italian experience with 2,515 patients. Obes Surg 2005; 15: 1161-4.
4. Herve J, Wahlen CH, Schaeken A et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005; 15: 864-70.
5. Mion F, Napoleon B, Roman S et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obes Surg 2005; 15: 510-6.
6. Alfalah H, Philippe B, Ghazal F et al. Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity. Obes Surg 2006; 16: 147-50.
7. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI ≥50). Obes Surg 2005; 15: 612-7.
8. Melissas J, Mouzas J, Filis D et al. The intragastric balloon - smoothing the path to bariatric surgery. Obes Surg 2006; 16: 897-902.
9. Schapiro M, Benjamin S, Blackburn G et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19-21, 1987. Gastrointest Endosc 1987; 33: 323-7.
10. Roman S, Napoleon B, Mion F et al. Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2004; 14: 539-44.
11. Sallet JA, Marchesini JB, Paiva DS et al. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14: 991-8.
12. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2005; 15: 101-5.
13. Forestieri P, De Palma GD, Formato A et al. Heliosphere Bag in the treatment of severe obesity: preliminary experience. Obes Surg 2006; 16: 635-7.
14. Kolotkin RL, Crosby RD, Kosloski KD et al. Development of a brief measure to assess quality of life in obesity. Obes Res 2001; 9: 102-11.
15. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982;1:198-9.
16. Boyle TM, Agus SG, Bauer JJ. Small intestinal obstruction secondary to obturation by a Garren gastric bubble. Am J Gastroenterol 1987; 82: 51-3.
17. Ulicny KS Jr, Goldberg SJ, Harper WJ et al. Surgical complications of the Garren-Edwards gastric bubble. Surg Gynecol Obstet 1988; 166: 535-40.
18. Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology 1990; 99: 362-9.
19. Doldi SB, Micheletto G, Perrini MN et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 2002; 12: 583-7.
20. Wright TA. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg 2002; 89: 489.
21. Zago S, Kornmuller AM, Agagliati D et al. [Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery]. Minerva Med 2006; 97: 51-64.
22. Totte E, Hendrickx L, Pauwels M et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg 2001; 11: 519-23.
23. Gale SM, Castracane VD, Mantzoros CS. Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J Nutr 2004; 134: 295-8.
24. Infanger D, Baldinger R, Branson R et al. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects. Obes Surg 2003; 13: 879-88.
25. Valsamakis G, McTernan Pg P, Chetty R et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-4.
26. Druce MR, Small CJ, Bloom SR. Gut peptides regulating satiety. Endocrinology 2004; 145: 2660-5.
27. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.